Proteomics Market Research Reports & Industry Analysis

Market Research > Browse Research > Life Sciences > Biotechnology

Proteomics Industry Research & Market Reports

Drug Discovery Technologies 2/1/2015 \| published by: BCC Research ... (CAGR) of 11.3% to nearly $79.5 billion for the period 2014-2019. This report provides: An overview of the global markets for drug discovery technologies. Analyses of global market trends, with data from 2012-2014, and projections ... \| read more...	USD 6,650
China mouse nerve growth factor injection industry, 2015 1/22/2015 \| published by: Reports From China ... from China, to build factories and take advantage of lower costs in China, to partner with one of the key Chinese corporations, to get market shares as China is boosting its domestic needs; to forecast ... \| read more...	USD 3,600
Proteomics: Technologies and Global Markets 2/1/2015 \| published by: BCC Research ... of $11.6 billion by 2019. This report provides: An overview of the global proteomics market, which covers: technologies, database and software markets, equipment markets, application markets and service markets. Analyses of global market trends, with ... \| read more...	USD 6,650
Lyophilized Injectables Devices, Markets, Players, Strategies and Forecasts 1/1/2015 \| published by: Greystone Research Associates ... special conditions or formulated to retain their efficacy from the time of manufacture until they are dispensed. Liquid protein drugs require refrigeration until dispensed – a requirement referred to as the ‘cold chain’. Alternatively, proteins ... \| read more...	USD 3,850
Proteomics (Global) - Industry Report 1/5/2015 \| published by: Plimsoll Publishing Ltd. ... the 70 largest Proteomics (Global) companies. The Proteomics (Global) report contains the most-up-to-date financial data and Plimsoll applies these figures to create their unique and authoritative analysis. Indeed, the first section thoroughly scrutinises the market ... \| read more...	USD 1,520
Proteins in Oncology Drug Pipeline Update 2015 1/5/2015 \| published by: BioSeeker Group AB ... are 2 suspended drugs and the accumulated number of ceased drugs over the last years amount to another 200 drugs. Proteins In Oncology Drug Pipeline Update lists all drugs and gives you a progress analysis ... \| read more...	USD 6,746
Cloud Market In Healthcare technologies, EHR Market, Digital pathology market, Clinical, EMR, SaaS, Bioinformatics, Digital pathology, Hybrid Market - Global Trends, Challenges, Opportunities & Forecasts 2014 – 2020 1/13/2015 \| published by: Occams Business Research & Consultancy ... maintenance and management of a large amount of data stored in a centralized database that can be accessed when needed. It saves a rather significant amount of infrastructural costs. Healthcare industry has lagged behind other ... \| read more...	USD 4,000
Molecular Weight Marker Market by Products (DNA, RNA, Protein Ladders), Type (Prestained, Specialty), Application (PCR, Western Blotting, Gel Extraction), & End User (Academic Institutes, Pharmaceutical Companies, CRO) - Global Forecast to 2019 1/5/2015 \| published by: MarketsandMarkets ... molecular weight markers market comprises of DNA, Protein and RNA markers. The molecular weight markers market is further divided on the basis of type and size. The molecular weight markers by type consist of 3 ... \| read more...	USD 4,650
Proteins in Oncology: Drug Pathway Analyzer 2015 1/12/2015 \| published by: BioSeeker Group AB ... than 85 different tumor types. The rational for this plethora of treatment strategies is based on our increasing understanding of the 163 drug targets that are included in this drug-pathway analyzing tool. No less than ... \| read more...	USD 6,746
Proteomics Markets for Research and IVD Applications (Mass Spectrometry, Chromatography, Microarrays, Electrophoresis, Immunoassays, Other Technologies) 9/4/2014 \| published by: Kalorama Information ... proteins. This includes the study of which proteins are expressed, when and where they are expressed, structure of proteins, roles of proteins, and interactions of proteins. Proteomics is a large field that has focused on ... \| read more...	USD 4,200
Single Use Bioreactor Market by Product Type (Recombinant Proteins, Monoclonal Antibodies), Cell Type (Bacteria, Yeast), Technology (Stirred SUB, Single Use Bubble Column Bioreactor), End User(Bio pharmaceutical Manufacturers) - Global Forecast to 2019 11/3/2014 \| published by: MarketsandMarkets ... such as China and India are lucrative markets for single-use bioreactors (SUB), owing to the low cost benefits offered by these nations. The report segments the global SUB market by molecule type, type of cell, ... \| read more...	USD 4,650
China Recombinant Protein Drug Industry Report, 2014-2017 11/19/2014 \| published by: Research in China ... protein drugs available in Chinese sample hospitals grew at a CAGR of 19.1%, and it is projected that China will see its actual demand for recombinant protein drugs exceed RMB40 billion in 2014. The start ... \| read more...	USD 2,500
Fibroblast Growth Factor Receptor (FGFR) Agonists -Pipeline Insights, 2014 11/21/2014 \| published by: DelveInsight ... of the report is to establish the understanding for all the pipeline drugs that fall under Fibroblast Growth Factor Receptor (FGFR) Agonists. This report provides information on the therapeutic development based on the Fibroblast Growth ... \| read more...	USD 1,250
Fibroblast Growth Factor Receptor (FGFR) Inhibitors -Pipeline Insights, 2014 11/21/2014 \| published by: DelveInsight ... of the report is to establish the understanding for all the pipeline drugs that fall under Fibroblast Growth Factor Receptor (FGFR) Inhibitors. This report provides information on the therapeutic development based on the Fibroblast Growth ... \| read more...	USD 1,250
Fibroblast Growth Factor Receptor 1 (FGFR1) Agonists -Pipeline Insights, 2014 11/21/2014 \| published by: DelveInsight ... key objective of the report is to establish the understanding for all the pipeline drugs that fall under Fibroblast Growth Factor Receptor 1 (FGFR1) Agonists. This report provides information on the therapeutic development based on ... \| read more...	USD 1,250
Fibroblast Growth Factor Receptor 1 (FGFR1) Inhibitors -Pipeline Insights, 2014 11/21/2014 \| published by: DelveInsight ... key objective of the report is to establish the understanding for all the pipeline drugs that fall under Fibroblast Growth Factor Receptor 1 (FGFR1) Inhibitors. This report provides information on the therapeutic development based on ... \| read more...	USD 1,250
G-Protein Coupled Receptor (GPCR) Agonists -Pipeline Insights, 2014 11/21/2014 \| published by: DelveInsight ... report is to establish the understanding for all the pipeline drugs that fall under G-Protein Coupled Receptor (GPCR) Agonists. This report provides information on the therapeutic development based on the G-Protein Coupled Receptor (GPCR) Agonists ... \| read more...	USD 1,250
Epigenetics Market by Product (Modifying Enzymes, DNA Polymerase, Acetylase, Methyltransferase, Instruments & Consumables, Kit, Bisulphite Conversion Kit, Reagents), Research Area (Developmental Biology, Oncology) & by End User - Global Forecast to 2019 9/29/2014 \| published by: MarketsandMarkets ... report, the global epigenetics market is segmented on the basis of products, research areas, and end users. The product segments of the epigenetics market included in this report are enzymes, instruments & consumables, kits, and ... \| read more...	USD 4,650
Fibroblast Activation Protein (FAP or Seprase) Inhibitors -Pipeline Insights, 2014 11/21/2014 \| published by: DelveInsight ... key objective of the report is to establish the understanding for all the pipeline drugs that fall under Fibroblast Activation Protein (FAP or Seprase) Inhibitors. This report provides information on the therapeutic development based on ... \| read more...	USD 1,250
Fibroblast Growth Factor (FGF) Inhibitors -Pipeline Insights, 2014 11/21/2014 \| published by: DelveInsight ... report is to establish the understanding for all the pipeline drugs that fall under Fibroblast Growth Factor (FGF) Inhibitors. This report provides information on the therapeutic development based on the Fibroblast Growth Factor (FGF) Inhibitors ... \| read more...	USD 1,250
Fibroblast Growth Factor 1 (FGF-1) Inhibitors -Pipeline Insights, 2014 11/21/2014 \| published by: DelveInsight ... of the report is to establish the understanding for all the pipeline drugs that fall under Fibroblast Growth Factor 1 (FGF-1) Inhibitors. This report provides information on the therapeutic development based on the Fibroblast Growth ... \| read more...	USD 1,250
Fibroblast Growth Factor Receptor 2 (FGFR2) Inhibitors -Pipeline Insights, 2014 11/21/2014 \| published by: DelveInsight ... key objective of the report is to establish the understanding for all the pipeline drugs that fall under Fibroblast Growth Factor Receptor 2 (FGFR2) Inhibitors. This report provides information on the therapeutic development based on ... \| read more...	USD 1,250
Fibroblast Growth Factor Receptor 3 (FGFR3) Inhibitors -Pipeline Insights, 2014 11/21/2014 \| published by: DelveInsight ... key objective of the report is to establish the understanding for all the pipeline drugs that fall under Fibroblast Growth Factor Receptor 3 (FGFR3) Inhibitors. This report provides information on the therapeutic development based on ... \| read more...	USD 1,250
Fibroblast Growth Factor Receptor 4 (FGFR4) Inhibitors -Pipeline Insights, 2014 11/21/2014 \| published by: DelveInsight ... key objective of the report is to establish the understanding for all the pipeline drugs that fall under Fibroblast Growth Factor Receptor 4 (FGFR4) Inhibitors. This report provides information on the therapeutic development based on ... \| read more...	USD 1,250
Metabolomics: Technologies and Applications - A Global Market Overview 11/26/2014 \| published by: Industry Experts ... the lingering uncertainties as to the advantages offered by metabolomics that have been the outcome of failed proteomics and genomics research programs. Through some recent accomplishments have been able to dispel some of these doubts, ... \| read more...	USD 4,410

< prev 1 2 3 4 5 next >